Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Minerva Med ; 76(42): 2007-10, 1985 Nov 03.
Artículo en Italiano | MEDLINE | ID: mdl-4069412

RESUMEN

13 cases of MVP in pregnancy were examined and compared with a control group. No significant differences were found in the various parameters assessed in the two groups nor did there appear to be any significant increase in obstetric or neonatal risk.


Asunto(s)
Prolapso de la Válvula Mitral , Complicaciones Cardiovasculares del Embarazo , Adulto , Puntaje de Apgar , Femenino , Humanos , Recién Nacido , Prolapso de la Válvula Mitral/diagnóstico , Complicaciones del Trabajo de Parto/etiología , Embarazo , Complicaciones Cardiovasculares del Embarazo/diagnóstico , Riesgo
2.
Minerva Cardioangiol ; 41(12): 569-74, 1993 Dec.
Artículo en Italiano | MEDLINE | ID: mdl-8139776

RESUMEN

Hypertension resistant to pharmacological treatment may be caused by various factors. Next to the real refractory forms, there is one of false resistance known as "pseudoresistance". Pseudoresistance is a condition with a discrepancy between blood pressure values measured at the physician's office, which appear falsely high, compared to those measured at home by the patient or with the 24-hour ambulatory blood pressure monitoring which appear to be within the normal range. We have studied 10 pseudoresistant patients and valued their average pressures measured at the doctor's office (158/96 mmHg), comparing them with those measured at home by the patients or family members (135/83 mmHg) and with those measured with 24 hour PA monitoring with Takeda monitor mod. 2420 (average values of daytime pressure 129/79 mmHg). The difference between values at the physician's office and those measured with the 24 hour ambulatory blood pressure monitoring have resulted statistically significant (p < 0.0001). In all those patients with hypertension treated pharmacologically we recommend the use of 24 hour ambulatory blood pressure monitoring, so as to evaluate realistically the efficacy of the therapy itself and to identify other potential "pseudoresistant" individuals.


Asunto(s)
Antihipertensivos/antagonistas & inhibidores , Hipertensión/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Presión Sanguínea/efectos de los fármacos , Monitores de Presión Sanguínea , Resistencia a Medicamentos , Quimioterapia Combinada , Femenino , Humanos , Hipertensión/fisiopatología , Masculino , Persona de Mediana Edad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA